Frequently Asked Questions
The Middle East and Africa Rice Protein Based Infant Formula Market size will be worth USD 0.10 billion by 2028.
The Middle East and Africa Rice Protein Based Infant Formula Market growth rate will be 7.80% by 2028.
The rise in the prevalence of breast cancer and surge in the number of infant population are the growth drivers of the Middle East and Africa Rice Protein Based Infant Formula Market.
The type, product type, form, infant age and distribution channel are the factors on which the Middle East and Africa Rice Protein Based Infant Formula Market research is based.
The Nucitec S.A. de C.V., Bayer AG, Ordesa, La Mandorle, Kate Farms, Lactalis International, BIOLAB PHARMA and Novalac are the major companies in the Middle East and Africa Rice Protein Based Infant Formula Market.
